Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anaemic dialysed uraemic patients.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Nephrology, Dialysis and Transplantation

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/NDT/6.1.31PMID 1829146
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Erythropoietin: a brief review.

  1989cited by this paper
• Regression of left ventricular mass is accompanied by improvement in rapid left ventricular filling following antihypertensive therapy with metoprolol.

  1989cited by this paper
• Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal disease.

  1989cited by this paper
• Correction of anaemia with recombinant human erythropoietin.

  1989cited by this paper
• Echocardiographic findings in patients on maintenance hemodialysis substituted with recombinant human erythropoietin.

  1989cited by this paper
• Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure.

  1989cited by this paper
• Congestive heart failure in dialysis patients.

  1988cited by this paper
• Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults.

  1988cited by this paper
• Analysis of left-ventricular changes associated with chronic hemodialysis. A noninvasive follow-up study.

  1988cited by this paper
• Protective effect of a prostacyclin-mimetic on the ischaemic-reperfused rabbit myocardium.

  1988cited by this paper
• Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.

  1987cited by this paper
• Left ventricular hypertrophy in end-stage renal disease on peritoneal dialysis.

  1987cited by this paper
• Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

  1986cited by this paper
• Serial effects on left ventricular load and contractility during hemodialysis in patients with concentric hypertrophy.

  1986cited by this paper
• Intertest variability of echocardiographic and chest X-ray measurements: implications for decision making in patients with aortic regurgitation.

  1986cited by this paper
• Asymmetric septal hypertrophy and sympathetic overactivity in normotensive hemodialyzed patients.

  1985cited by this paper
• Report of the Joint International Society and Federation of Cardiology /World Health Organization Task Force on Recommendations for Standardization of Measurements from M-mode Echocardiograms.

  1984cited by this paper
• Left ventricular function in chronic anemia: evidence of noncatecholamine positive inotropic factor in the serum.

  1984cited by this paper
• Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy.

  1984cited by this paper
• Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension.

  1984cited by this paper
• Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress.

  1983cited by this paper
• Pathogenesis of cardiac hypertrophy in iron deficiency anaemia: the role of noradrenaline.

  1982cited by this paper
• Simple and fast solvent extraction system for selective and quantitative isolation of adrenaline, noradrenaline and dopamine from plasma and urine.

  1982cited by this paper
• Acute effects of haemodialysis on left heart dimensions and left ventricular function: an echocardiographic study.

  1981cited by this paper
• Cardiac sympathetic nerves as the final common pathway in the induction of adaptive cardiac hypertrophy.

  1981cited by this paper
• Plasma catecholamine response to postural stimulation in normotensive and dialysis hypotension-prone uremic patients.

  1981cited by this paper
• Blood pressure control in end-stage renal disease in man: indirect evidence of a complex pathogenic mechanism besides renin or blood volume.

  1977cited by this paper
• Cardiac work demands and left ventricular function in end-stage renal disease.

  1977cited by this paper
• Cellular Hyperplasia and Hypertrophy in Cardiomegalies Induced by Anemia in Young and Adult Rats

  1972cited by this paper

• Echocardiogram screening in pediatric dialysis and transplantation

  2022influential citation
• Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations

  2022cites this paper
• Association between Anti-Erythropoietin Receptor Antibodies and Cardiac Function in Patients on Hemodialysis: A Multicenter Cross-Sectional Study

  2022cites this paper
• CARDIAC DISEASE IN RENAL FAILURE

  2020cites this paper
• Identifying Biomarker Profiles Through the Epidemiologic Analysis of Big Health Care Data – Implications for Clinical Management and Clinical Trial Design

  2020cites this paper
• Improved blood pressure and left ventricular remodelling in children on chronic intermittent haemodialysis: a longitudinal study

  2019cites this paper
• Association of Pre-End-Stage Renal Disease Hemoglobin with Early Dialysis Outcomes

  2018cites this paper
• Anemia as a risk factor for all-cause mortality: obscure synergic effect of chronic kidney disease

  2017cites this paper
• Probing Dry-Weight Improves Left Ventricular Mass Index

  2016cites this paper
• Biomedical system dynamics to improve anemia control with darbepoetin alfa in long-term hemodialysis patients.

  2014cites this paper
• Hepcidin and iron metabolism disorders in patients with chronic kidney disease Hepcidin i poremeaji metabolizma gvoˇ a kod bolesnika sa hroni˛ nom bubrenom boleš¸ u

  2013cites this paper
• Hepcidin and iron metabolism disorders in patients with chronic kidney disease.

  2013cites this paper
• Morbidity and Mortality in Anemia 3 2 . 3 Folic acid deficiency anemia

  2012influential citation
• Call to arms….

  2012cites this paper
• Cardiovascular outcomes associated with anaemia of chronic kidney disease and its therapy.

  2012cites this paper
• The Association between Hemoglobin Concentrations and Cardiovascular Disease in Postmenopausal Women within the Women's Health Initiative

  2012cites this paper
• Morbidity and Mortality in Anemia

  2012cites this paper
• Comparative Mortality Risk of Anemia Management Practices in Incident Hemodialysis Patients

  2010cites this paper
• Long-term effects of arteriovenous fistula closure on echocardiographic functional and structural findings in hemodialysis patients: a prospective study.

  2010cites this paper
• Probing Dry-Weight Improves Left Ventricular Mass Index

  2010cites this paper
• Comparative mortality risk of anemia management practices in incident hemodialysis patients.

  2010cites this paper
• Use of Recombinant Human Erythropoietin in Renal Anemia in Children

  2009cites this paper
• Hemoglobin is inversely related to flow-mediated dilatation in chronic kidney disease.

  2009cites this paper
• Molecular Basis of Cardioprotection by Erythropoietin

  2009cites this paper
• Molecular basis of cardioprotection by erythropoietin.

  2009cites this paper
• NON‐CORONARY HEART DISEASE IN DIALYSIS PATIENTS: Hypertrophy and Fibrosis in the Cardiomyopathy of Uremia—Beyond Coronary Heart Disease

  2008cites this paper
• Association between number of months below K/DOQI haemoglobin target and risk of hospitalization and death.

  2008cites this paper
• Reviews: Is Regression of Left Ventricular Hypertrophy in Maintenance Hemodialysis Patients Possible?

  2008cites this paper
• Critiques of Clinical Guidelines in Nephrology: Anaemia

  2008cites this paper
• Anemia treatment in chronic kidney disease: shifting uncertainty

  2008cites this paper
• L-carnitine supplementation decreases the left ventricular mass in patients undergoing hemodialysis.

  2008cites this paper
• The economic burden of end-stage renal disease in Canada.

  2007cites this paper
• Time to target haemoglobin concentration (11 g/dl)--risk of hospitalization and mortality among incident dialysis patients.

  2007cites this paper
• The evaluation of the uraemic heart using cardiovascular magnetic resonance imaging

  2007influential citation
• Iron indices: what do they really mean?

  2006cites this paper
• Reduction of left ventricular hypertrophy in children undergoing hemodialysis

  2006cites this paper
• Effect of preload reduction by hemodialysis on myocardial ultrasonic characterization, left atrial volume, and Doppler tissue imaging in patients with end-stage renal disease.

  2006cites this paper
• Update on erythropoietin treatment: should hemoglobin be normalized in patients with chronic kidney disease?

  2006cites this paper
• [Cardiorenal anemic syndrome: clinical significance and therapeutic principles].

  2005cites this paper
• Effects of Optimized Heart Failure Therapy and Anemia Correction with Epoetin β on Left Ventricular Mass in Hemodialysis Patients

  2005cites this paper
• Dose tailoring strategies in haemodialysis patients: a discussion of case histories.

  2005cites this paper
• Effect of Recombinant Erythropoietin on Hospital Admissions, Readmissions, Length of Stay, and Costs of Dialysis Patients”2

  2005cites this paper
• Intractable anemia among hemodialysis patients: a sign of suboptimal management or a marker of disease?

  2005cites this paper
• Anaemia and the heart

  2005cites this paper
• Quotidian Nocturnal Hemodialysis Improves Cytokine Profile and Enhances Erythropoietin Responsiveness

  2005cites this paper
• Epoetin alfa's effect on left ventricular hypertrophy and subsequent mortality.

  2005cites this paper
• Dialysis techniques: hemodialysis

  2004cites this paper
• Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial.

  2004cites this paper
• Erythropoietic agents, iron and hemoglobin—What happens beyond the trial setting: Observational data from the ANZDATA Registry

  2004cites this paper
• Angiotensin Receptor Antagonist Regresses Left Ventricular Hypertrophy Associated with Diabetic Nephropathy in Dialysis Patients

  2004cites this paper
• Achieving therapeutic targets in renal anaemia: considering cost-efficacy

  2004cites this paper
• Comparison of the Effects of Angiotensin Receptor Antagonist, Angiotensin Converting Enzyme Inhibitor, and their Combination on Regression of Left Ventricular Hypertrophy of Diabetes Type 2 Patients on Recent Onset Hemodialysis Therapy

  2004cites this paper
• Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial

  2004cites this paper
• Epoetin Alfa Resistance: Valuation of a Management Algorithm

  2004cites this paper
• Management of anemia in patients with chronic kidney disease

  2004cites this paper
• Untersuchung zum Einfluß des ACE Gen Polymorphismus auf die Entwicklung einer linksventrikulären Hypertrophie bei Patienten mit terminaler Niereninsuffizienz.

  2004cites this paper
• Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children

  2003cites this paper
• Anemia: not just an innocent bystander?

  2003cites this paper
• Calcium-channel blockers and end-stage renal disease: pharmacokinetic and pharmacodynamic considerations

  2003cites this paper
• Transfusion medicine: looking to the future.

  2003cites this paper
• Traditional and emerging cardiovascular risk factors in end-stage renal disease.

  2003cites this paper
• Tolerability and Efficacy of Multidose Epoetin Beta (Reco-Pen®) for Subcutaneous Administration in Patients with Anemia due to Renal Failure

  2003cites this paper
• Einfluß von Endothelin-Rezeptor-Antagonisten, Losartan und Nebivolol auf die Isoformen der myokardialen Protein Kinase C in der Urämie

  2003cites this paper
• Uremic toxicity and anemia.

  2003cites this paper
• THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Hemodynamic Cardiovascular Risk Factors in Chronic Kidney Disease: What are the Effects of Intervention?

  2003cites this paper
• Safety in iron management.

  2003cites this paper
• THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Cardiovascular Disease in Chronic Renal Failure: Pathophysiologic Aspects

  2003cites this paper
• Anaemia of chronic kidney disease: an under-recognized and under-treated problem.

  2002cites this paper
• Recurrence of left ventricular hypertrophy following cessation of erythropoietin therapy.

  2002cites this paper
• αβ and γδ T cell subsets in chronic renal failure in children on dialysis treatment

  2002cites this paper
• Left ventricular geometry and adverse cardiovascular events in chronic hemodialysis patients on prolonged therapy with ACE inhibitors.

  2002cites this paper
• Improved survival rates at Başkent University hemodialysis centers through continuous quality improvement.

  2002cites this paper
• Regression der linksventrikulären Hypertrophie und Verbesserung der diastolischen Funktion bei terminaler Niereninsuffizienz nach Nierentransplantation - eine prospektive echokardiographische Untersuchung

  2002cites this paper
• Optimizing dose and mode of renal replacement therapy in anaemia management.

  2002cites this paper
• Review: The pharmacokinetics and pharmacodynamics of angiotensin-receptor blockers in end-stage renal disease

  2002cites this paper
• Should Hemoglobin be Normalized in Patients with Chronic Kidney Disease?

  2002cites this paper
• Left ventricular alterations and end-stage renal disease.

  2002cites this paper
• Anemia treatment in the pre-ESRD period and associated mortality in elderly patients.

  2002cites this paper
• Effect of erythropoietin on cardiovascular diseases.

  2001cites this paper
• Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study.

  2001cites this paper
• The Heart in Renal Failure: Morphological Changes of the Myocardium - New Insights

  2001cites this paper
• Dialysis: its role in optimizing recombinant erythropoietin treatment.

  2001cites this paper
• Pathophysiology of anaemia: focus on the heart and blood vessels.

  2000cites this paper
• Pathophysiology of cardiovascular disease in hemodialysis patients.

  2000cites this paper
• Should the Hematocrit (Hemoglobin) Be Normalized in Pre-ESRD or Dialysis Patients? Yes!

  2000cites this paper
• Tolerability of the Epoetin-Beta Multidose Formulation (Reco-Pen®) in Patients with Renal Anaemia

  2000cites this paper
• Effect of high-flux dialysis on the anaemia of haemodialysis patients.

  2000cites this paper
• Anemia management in patients with chronic renal insufficiency.

  2000cites this paper
• Sensitive Detection of Myocardial Contraction Abnormality in Chronic Hemodialysis Patients by Ultrasonic Tissue Characterization with Integrated Backscatter

  2000cites this paper
• Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients.

  2000cites this paper
• THE EFFECTS OF NORMAL AS COMPARED WITH LOW HEMATOCRIT VALUES IN PATIENTS WITH CARDIAC DISEASE WHO ARE RECEIVING HEMODIALYSIS AND EPOETIN

  2000cites this paper
• Anemia of hemodialysis patients: evaluation of the effect of BK-F polymethylmethacrylate membrane.

  1999cites this paper
• Pressure-overload cardiomyopathy in end-stage renal disease

  1999cites this paper
• Should anaemia in subtypes of CRF patients be managed differently?

  1999cites this paper
• What are the short-term and long-term consequences of anaemia in CRF patients?

  1999cites this paper
• Should anaemia in subtypes of CRF patients be managed differently

  1999cites this paper
• Morbidity and mortality in redefining adequacy of peritoneal dialysis: a step beyond the National Kidney Foundation Dialysis Outcomes Quality Initiative.

  1999cites this paper
• Hypervolemia in dialysis patients--Doppler echocardiography studies.

  1998cites this paper
• Methods of literature review and synthesis.

  1998cites this paper
• Angiotensin-converting enzyme gene polymorphism and reversibility of uremic left ventricular hypertrophy following long-term antihypertensive therapy.

  1998cites this paper